Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
allogeneic adipose derived mesenchymal stem cell (1 trial)
Key: Cesca Therapeutics, Inc. (0) Acquired (1)
bone autograft (2 trials)
platelet-rich plasma (1 trial)
Ischemia (Phase 3)
Trials (4 total)
Trial APIs (3 total)